ABSTRACT BACKGROUND: Ocular neovascularization (NV) is the one of the major causes of blindness in many ocular diseases. Currently, the administration of anti-VEGF agents has been widely accepted for the clinical management of these devastating diseases. However, the short effective duration and the non-responsive rate due to the protein nature of the anti-VEGF antibodies warrants further investigations to explore alternative angiogenic suppressants. Evidence suggested that microRNA-370 could inhibit the formation of vessels. However, the exact mechanism has not yet been clarifi ed. AIM: To investigate the regulatory role of microRNA-370 in the growth and apoptosis of retinal capillary endothelial cells and association between microRNA-370 and kinase insert domain-containing receptor (KDR) gene. METHODS: The effects of miRNA-370 on cell cycle and apoptosis, as well as the expression of cycle-and apoptosis-related genes, were determined using MTT, TUNEL assay, qRT-PCR, and Western blot. The direct target of miRNA-370 was confi rmed using 3′ untranslated region (UTR) luciferase reporter assay. RESULTS: The miRNA-370 induced growth inhibition and apoptosis of retinal capillary endothelial cell while the inhibition of miRNA-370 reversed these effects. miRNA-370 upregulated the expression of CyclinD1, p21, p27, FasL, and Bim. Furthermore, miR-370 directly reduced the expression of KDR by targeting its 3′untranslated region. CONCLUSION: MicroRNA-370 inhibits the expression of KDR gene resulting in retinal capillary endothelial cell growth inhibition and apoptosis, which could be of value in the treatment of retinal neovascularization (Tab. 1, Fig. 5, Ref. 27). Text in PDF www.elis.sk.
Introduction
Ocular neovascularization (NV) is the primary cause of blindness in a wide range of ocular diseases such as diabetic retinopathy (DR), age-related macular degeneration (AMD), retinopathy of prematurity (ROP), central and branch retina vein occlusion (CRVO and BRVO), trauma and various infl ammatory ocular diseases (1, 2) . Retinal and choroidal vascular diseases constitute the most common causes of moderate and severe vision loss in developed countries (3) . Vascular endothelial growth factor (VEGF) plays a central role in the development of several types of ocular NV. Currently, the administration of anti-VEGF agents has been widely accepted for the clinical management of these devastating diseases (4) (5) (6) . However, the short duration of effect and non-responsive rate due to the protein nature of the anti-VEGF antibodies warrant further investigations to explore alternative angiogenic suppressants (7, 8) .
Evidence suggested that microRNA-370 could inhibit the formation of vessels by targeting at the gene expression. Advancements in understanding the basic mechanisms of the angiogenic process have led to the identifi cation of several macromolecules containing the potential capacity of angiostasis (1) . Among the reported data, microRNAs, endogenous non-coding RNA molecules, demonstrated a promising capacity in regulating the cell proliferation, migration and transdifferentiation by regulating the gene translation post-transcriptionally through the pairing with the 3'-untranslated region of the target DNA (9, 10) .
Inhibition of VEGF signaling has shown to be greatly promising for the treatment of ocular neovascular disease. KDR is one of the promising therapeutic targets to be manipulated in order to stop the angiogenic process, which is a complex process involving many cells and cytokines. Among the large number of growth factors involving in the angiogenesis, VEGF plays a predominant role in the process by signaling through its ligand on the cellular membrane. The binding of VEGF to its receptor initiates a signal transduction cascade mediating vascular endothelial cell proliferation and migration, which eventually results in the formation of abnormal new vessels (11) . VEGF receptor-2 (also known as KDR) is encoded by major membrane receptor for VEGF signaling (12) . Previous report showed that the blocking of KDR with a specifi c antibody could result in the prevention of new vessel formation (13) . The inhibition of KDR was reported to reduce the size of the choroidal neovascularization in animal models (14) . Furthermore, it has been suggested that the microRNA-370 might be able to regulate the expression of VEGF receptor-2 by binding to KDR gene, which could decrease the sensitivity of the cells to the increased level of VEGF. Therefore, we constructed the microRNA-370 overexpression and inhibition model of retinal capillary endothelial cells to examine the regulatory role of microRNA-370 in cellular proliferation, apoptosis and angiogenesis.
Material and methods

Cell culture
Human retinal capillary endothelial cells (HRCEC, JENNIO biological technology, Guangzhou, PRC) were maintained in HRCEC medium provided by the manufacturer incubated at 37 °C with 5 % CO 2 .
Lentivirus construction and transfection Establishment of cell lines expressing miR-370
Lentiviral vectors were used to establish stable cell lines expressing miR-370. Psin-EF2-miR-150-IRES-GFP-puro expressing miR-370 pre-miRNA was constructed using specifi c primers, 5′-GCCGAATTCTTGAACTAATTCATTTCTTT -3′ (forward) and 5′-GCCGGATCCCGTCTCTGTGCCTGTTTCCC -3′ (reverse). The 293T cells were used to generate lentivirus containing the sequences of miR-370 precursor. The 293T cells were co-transfected with pMD2.G, pSPAX2 and Psin-EF2-miR-370-IRES-GFP-puro using Lipofectamine 2000 Transfection Regent (Invitrogen, Waltham, MA). After 48 h, the supernatant was collected and fi ltered using 0.22 um fi lter. Filtered supernatant containing lentivirus was then used for transduction.
HRCEC cells were plated on 6-well plates and incubated to 40 % confl uence. The cells were infected with lentivirus for 4 h and cultured with MEM medium containing 10 % of FBS and including polybrane (4 μg/mL). Then the medium was changed to MEM medium containing 10 % of FBS and the infection procedure was repeated. Afterwards, the cells were incubated for 48 hours in fresh MEM medium containing 10% of FBS. Expand cells were then used for further experiments and transduction effi ciency was measured by a fl uorescence microscope (Olympus, Japan). A control cell line transducted with empty vectors was also established using the same procedure.
Cell growth assay
HRCEC cells (1 × 10 4 ) expressing miRNA-370 or inhibitors were cultured in a 24-well plate for 4 days, and the cell number of the cells was determined every day. This assay was performed in triplicate and repeated in three independent experiments.
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay
TUNEL assay combined with propidium iodide (PI) staining were used to identify the ratio of apoptosis versus total cell number. Briefl y, the HRCEC cells cultured in high glucose culture medium (33 mmol/L) were transfected with microRNA-370 vector or inhibitor as aforementioned. Afterwards, the cells were fi xated by 4 % paraformaldehyde for 5 minutes. Then, the cells were stained with FITC-conjugated dUTP (green) and PI (red) follow the protocol of the manufacturer. The apoptotic cells and the total cells' number were counted using a fl uorescent microscope (Olympus, Japan). The assays were triplicated.
Western blot
Whole-cell lysates were extracted from cells suspended in the immune precipitation buffer (Beyotime, China). Lysates were separated by electrophoresis on polyacrylamide gels containing 0.1 % sodium dodecyl sulfate (SDS-PAGE) and then transferred to polyvinylidene difl uoride membranes. The membranes were blocked with 5 % non-fat milk in Tris Buffer Saline Tween 20 (TBST) buffer. The blots were incubated with the primary antibody and exposed to horseradish peroxidase (HRP)-conjugated secondary antibodies (goat anti mouse IgG or goat anti rabbit IgG depending on the primary antibody) afterwards. The bands on the membrane were visualized and captured using the ECL reagent (Beyotime) and documented on X-ray fi lms. The pixel densities of proteins were quantifi ed using ImageJ 1.47 software. Antibodies against to p27, p21, FasL, Bim and KDR as well as (HRP)-linked antimouse and -rabbit IgG, were bought from Beyotime.
Real-time PCR
Total RNA was isolated from HRCEC cells using trizol (Invitrogen, Carlsbad, CA) and reverse transcription of mRNA was performed using QuantScript RT kit (Tiangen) according to the manufacturer's protocol. RT-PCR was performed with SYBR Green Realtime PCR Kit (TOYOBO, JAPAN) and the Chromo4™ Real-Time PCR System (Bio-bad, US). The specifi c primer sequences for the genes are shown in Table 1 . Relative mRNA expression was carried out using 2−ΔΔCt method after normalization to GAPDH. 
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Luciferase reporter assay
Wild type or mutant 3′ untranslated region (UTR) of KDR containing the putative binding sites for miRNA-370 were subcloned into psiCHECK-2 Vectors. The constructed plasmids were transfected into HRCEC cells as well as cells expressing miR-370 or inhibitors using Lipofectamine 2000 Transfection Regent (Invitrogen). After 48 h, the luciferase activity in cell lysates was evaluated using the Dual-Luciferase Reporter Assay system according to the manufacturer's instructions (Promega, USA).
Statistical analysis
Statistical signifi cance for the experiments was determined using the Student's t test or One-way ANOVA. p < 0.05 was regarded as statistically signifi cant.
Results
miRNA-370 induced growth inhibition and apoptosis of HRCEC cells
To investigate the role of miRNA-370 in the retinal angiogenesis, the HRCEC cells were transfected with either the miRNA-370 vectors, miRNA-370 inhibitor or blank vector. The expression of miRNA-370 in each cell lines was measured by RT-PCR, which showed that the cells transfected with miRNA-370 vector had the highest level of miRNA-370 expression while the miRNA-370 inhibitor suppressed the expression of miRNA-370 (Fig. 1) . The relative proliferation ratios of the miRNA-370 overexpressing cells and the blank vector cells were calculated by using the normal HRCEC cells as the house hold control using MTT assay. The results showed that the proliferation ratios were signifi cantly higher in the cells treated with blank vectors compared to that in the cells overexpression miRNA-370, which suggested that miR-370 inhibited the proliferation of HRCEC cells (Fig. 2) . Additionally, the Tunnel assay showed that the overexpression of miRNA-370 in the HRCEC cells promoted apoptosis of HRCEC cells (Fig. 3) .
The miRNA-370 upregulated the expression of CyclinD1, p21, p27, FasL, and Bim in the HRCEC cells
The overexpression of miRNA-370 in the HRCEC cells upregulated the expression of CyclinD1, p21 and p27 which are known regulators inhibiting the cellular proliferation by regulating the cell cycle progression. Additionally, the results showed that the HRCEC cells producing high level of miRNA-370 expressed higher level of two pro-apoptotic genes, namely, FasL, and Bim, both on the protein level and mRNA level. The results were confi rmed by both western-blot and quantitative PCR (Fig. 4) . The inhibition of miRNA-370 resulted in the downregulation of the aforementioned factors.
The miR-370 directly reduced the expression of KDR by targeting its 3′ untranslated region (3′UTR)
We found signifi cant downregulation of KDR gene in the HRCEC cells overexpressing miRNA-370. The inhibition of miR-NA-370 resulted in the upregulation of KDR (Fig. 5) . To confi rm the direct interaction between miRNA-370 and 3'UTR or KDR, two luciferase reporter plasmids containing either the wild type or (Fig. 5 ).
Discussion
The results of the current study added further information about the correlation between increased miRNA-370 and ocular neovascularization. We observed anti-angiogenic effect of miR-NA-370 as miRNA-370 inhibited the proliferation and promoted apoptosis of retinal capillary endothelial cells. Additionally, KDR gene was identifi ed as a direct target of miRNA-370 which is directly linked to the formation of new vessels by regulating the expression of CyclinD1, p21, p27, FasL, and Bim. Therefore, we propose a hypothesis that miRNA-370 induces the transcriptional arrest of KDR by the binding of 3'-UTR and the upregulation of CyclinD1, p21, p27, FasL, and Bim, which eventually results in the suppression of capillary endothelial cell proliferation and the promotion of apoptosis.
Our results showed that miRNA-370 is pro-apoptotic which could inhibit the proliferation of HRCEC cells. The inhibitory function of miRNA-370 in the proliferation and pro-apoptotic effect has also been reported in other types of cells. It has been shown that miR-370 inhibited cell proliferation of liver cancer cells by PI3K/Akt signaling pathway (9) . The regulatory role of miRNA-370 in the cellular proliferation were reported during embryogenic process as well as a few types of cancer cells (10, 15, 16) . The mature miRNA recognized the target mRNAs by incorporating into a RNA-induced silencing complex (RISC) resulting in translational inhibition or destabilization of the target mRNA. Our results showed that the overexpression of miRNA-370 resulted in upregulation of FasL, and Bim, which are the known pro-apoptotic factors (17, 18) . Thus, the pro-apoptotic effect of miRNA-370 is functioned through these factors. Furthermore, the current study showed that the overexpression of miRNA-370 increased the expression of CyclinD1, p21 and p27, which are related to the regulation of cell cycle progression (19, 20) .
The current study identifi ed the KDR gene as a novel target of miRNA-370 as miR-370 suppressed the transcriptional process of KDR through targeting the 3′UTR of its mRNA. The direct targeting of miRNA-370 to the 3'UTR of the KDR gene shed some new light on the novel therapeutic approach to the ocular neovascularization. Although VEGF binds to VEGFR-1 with high affi nity, and less strongly to VEGFR-2 (21). The tyrosine kinase (TK) activity of KDR is about 10 fold stronger than VEGFR-1. Along with the results of gene knockout studies, previous reports indicated that the major signal transducer in angiogenesis is VEGFR-2 (12). The inhibition of KDR activities has been considered to be one of the potential promising targets for the prevention of neovascularization. Ahani et al reported that the nanobody carried by lentiviral vectors targeting the KDR could potentially reduce the neovascularization in tumor vasculature (22) . Other authors have also reported various approaches to inhibit the biological activity of KDR thus resulting in the inhibition of angiogenesis (23, 24) .
Since the VEGR-KDR axis has been reported to be involved in the cell migration, proliferation, differentiation as well as transducing cell survival signals, it is possible that the upregulation of CyclinD1, p21, p27, FasL, and Bim in the HRCEC cells is mediated by VEGF-KDR axis as well (25) (26) (27) .
